Lyell Immunopharma Stock Price History
LYEL Stock | USD 0.53 0.05 8.62% |
If you're considering investing in Lyell Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lyell Immunopharma stands at 0.53, as last reported on the 20th of March, with the highest price reaching 0.62 and the lowest price hitting 0.53 during the day. Lyell Immunopharma has Sharpe Ratio of -0.0183, which conveys that the firm had a -0.0183 % return per unit of risk over the last 3 months. Lyell Immunopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lyell Immunopharma's Standard Deviation of 5.58, risk adjusted performance of (0.06), and Mean Deviation of 4.19 to check out the risk estimate we provide.
At this time, Lyell Immunopharma's Stock Based Compensation is quite stable compared to the past year. Stock Based Compensation To Revenue is expected to rise to 570.51 this year, although the value of Capital Stock will most likely fall to about 27.6 K. . The value of Price To Sales Ratio is estimated to slide to 2,484. The value of Price Earnings Ratio is estimated to slide to -0.51. Lyell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lyell |
Sharpe Ratio = -0.0183
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | LYEL |
Estimated Market Risk
5.32 actual daily | 47 53% of assets are more volatile |
Expected Return
-0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lyell Immunopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lyell Immunopharma by adding Lyell Immunopharma to a well-diversified portfolio.
Price Book 0.4487 | Enterprise Value Ebitda 0.251 | Price Sales 2.8 K | Shares Float 201.6 M | Wall Street Target Price 0.8 |
Lyell Immunopharma Stock Price History Chart
There are several ways to analyze Lyell Stock price data. The simplest method is using a basic Lyell candlestick price chart, which shows Lyell Immunopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | March 7, 2025 | 0.74 |
Lowest Price | March 18, 2025 | 0.48 |
Lyell Immunopharma March 20, 2025 Stock Price Synopsis
Various analyses of Lyell Immunopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Lyell Stock. It can be used to describe the percentage change in the price of Lyell Immunopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Lyell Stock.Lyell Immunopharma Accumulation Distribution | 121,808 | |
Lyell Immunopharma Price Daily Balance Of Power | (0.56) | |
Lyell Immunopharma Price Action Indicator | (0.07) | |
Lyell Immunopharma Price Rate Of Daily Change | 0.91 |
Lyell Immunopharma March 20, 2025 Stock Price Analysis
Lyell Stock Price History Data
The price series of Lyell Immunopharma for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 0.37 with a coefficient of variation of 9.86. The daily prices for the period are spread out with arithmetic mean of 0.63. The median price for the last 90 days is 0.62.Open | High | Low | Close | Volume | ||
03/20/2025 | 0.60 | 0.62 | 0.53 | 0.53 | 839,121 | |
03/19/2025 | 0.54 | 0.63 | 0.52 | 0.58 | 2,330,674 | |
03/18/2025 | 0.51 | 0.55 | 0.48 | 0.48 | 1,259,510 | |
03/17/2025 | 0.59 | 0.59 | 0.51 | 0.52 | 1,182,212 | |
03/14/2025 | 0.60 | 0.62 | 0.59 | 0.59 | 1,017,265 | |
03/13/2025 | 0.68 | 0.68 | 0.58 | 0.61 | 605,103 | |
03/12/2025 | 0.68 | 0.70 | 0.62 | 0.67 | 599,605 | |
03/11/2025 | 0.70 | 0.72 | 0.66 | 0.67 | 482,514 | |
03/10/2025 | 0.73 | 0.73 | 0.67 | 0.68 | 489,846 | |
03/07/2025 | 0.74 | 0.78 | 0.70 | 0.74 | 922,983 | |
03/06/2025 | 0.69 | 0.74 | 0.67 | 0.73 | 908,276 | |
03/05/2025 | 0.72 | 0.72 | 0.69 | 0.70 | 622,318 | |
03/04/2025 | 0.66 | 0.71 | 0.63 | 0.70 | 1,234,148 | |
03/03/2025 | 0.71 | 0.71 | 0.65 | 0.66 | 660,904 | |
02/28/2025 | 0.72 | 0.72 | 0.67 | 0.71 | 725,767 | |
02/27/2025 | 0.71 | 0.73 | 0.68 | 0.71 | 1,090,412 | |
02/26/2025 | 0.67 | 0.71 | 0.65 | 0.70 | 1,141,072 | |
02/25/2025 | 0.69 | 0.72 | 0.64 | 0.66 | 549,550 | |
02/24/2025 | 0.71 | 0.77 | 0.66 | 0.67 | 1,881,660 | |
02/21/2025 | 0.68 | 0.73 | 0.67 | 0.70 | 1,094,843 | |
02/20/2025 | 0.63 | 0.69 | 0.62 | 0.66 | 1,422,749 | |
02/19/2025 | 0.60 | 0.62 | 0.60 | 0.62 | 630,521 | |
02/18/2025 | 0.61 | 0.62 | 0.57 | 0.61 | 812,789 | |
02/14/2025 | 0.61 | 0.63 | 0.59 | 0.61 | 1,760,996 | |
02/13/2025 | 0.55 | 0.60 | 0.53 | 0.58 | 3,384,169 | |
02/12/2025 | 0.53 | 0.56 | 0.51 | 0.54 | 1,334,192 | |
02/11/2025 | 0.55 | 0.56 | 0.51 | 0.54 | 2,221,733 | |
02/10/2025 | 0.58 | 0.58 | 0.55 | 0.55 | 2,031,144 | |
02/07/2025 | 0.60 | 0.60 | 0.57 | 0.57 | 721,839 | |
02/06/2025 | 0.62 | 0.63 | 0.57 | 0.59 | 3,959,131 | |
02/05/2025 | 0.61 | 0.64 | 0.60 | 0.62 | 809,280 | |
02/04/2025 | 0.59 | 0.63 | 0.58 | 0.60 | 1,006,729 | |
02/03/2025 | 0.57 | 0.61 | 0.57 | 0.58 | 867,506 | |
01/31/2025 | 0.60 | 0.60 | 0.57 | 0.59 | 873,771 | |
01/30/2025 | 0.61 | 0.61 | 0.55 | 0.58 | 523,600 | |
01/29/2025 | 0.61 | 0.64 | 0.57 | 0.58 | 585,170 | |
01/28/2025 | 0.64 | 0.64 | 0.60 | 0.61 | 458,272 | |
01/27/2025 | 0.59 | 0.65 | 0.59 | 0.63 | 1,344,594 | |
01/24/2025 | 0.58 | 0.63 | 0.58 | 0.61 | 792,748 | |
01/23/2025 | 0.57 | 0.61 | 0.57 | 0.58 | 482,456 | |
01/22/2025 | 0.58 | 0.60 | 0.57 | 0.58 | 810,400 | |
01/21/2025 | 0.59 | 0.61 | 0.57 | 0.57 | 884,999 | |
01/17/2025 | 0.56 | 0.60 | 0.56 | 0.58 | 601,915 | |
01/16/2025 | 0.60 | 0.61 | 0.56 | 0.56 | 913,405 | |
01/15/2025 | 0.58 | 0.62 | 0.58 | 0.60 | 582,655 | |
01/14/2025 | 0.60 | 0.61 | 0.55 | 0.57 | 1,805,003 | |
01/13/2025 | 0.60 | 0.60 | 0.58 | 0.59 | 771,517 | |
01/10/2025 | 0.62 | 0.64 | 0.60 | 0.60 | 895,936 | |
01/08/2025 | 0.66 | 0.66 | 0.63 | 0.65 | 676,849 | |
01/07/2025 | 0.68 | 0.71 | 0.66 | 0.66 | 623,862 | |
01/06/2025 | 0.71 | 0.72 | 0.67 | 0.68 | 877,392 | |
01/03/2025 | 0.65 | 0.72 | 0.65 | 0.70 | 821,414 | |
01/02/2025 | 0.64 | 0.68 | 0.64 | 0.65 | 740,447 | |
12/31/2024 | 0.63 | 0.65 | 0.62 | 0.64 | 625,577 | |
12/30/2024 | 0.63 | 0.65 | 0.60 | 0.62 | 883,538 | |
12/27/2024 | 0.65 | 0.70 | 0.64 | 0.65 | 686,528 | |
12/26/2024 | 0.60 | 0.70 | 0.60 | 0.65 | 895,100 | |
12/24/2024 | 0.61 | 0.63 | 0.60 | 0.61 | 742,278 | |
12/23/2024 | 0.62 | 0.64 | 0.60 | 0.62 | 798,571 | |
12/20/2024 | 0.62 | 0.64 | 0.60 | 0.61 | 2,807,578 | |
12/19/2024 | 0.60 | 0.66 | 0.58 | 0.64 | 2,804,884 |
About Lyell Immunopharma Stock history
Lyell Immunopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lyell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lyell Immunopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lyell Immunopharma stock prices may prove useful in developing a viable investing in Lyell Immunopharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 261.5 M | 274.2 M | |
Net Loss | -164.8 M | -173 M |
Lyell Immunopharma Quarterly Net Working Capital |
|
Lyell Immunopharma Stock Technical Analysis
Lyell Immunopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
All Next | Launch Module |
Lyell Immunopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lyell Immunopharma's price direction in advance. Along with the technical and fundamental analysis of Lyell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lyell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.32) | |||
Total Risk Alpha | 0.0359 | |||
Treynor Ratio | (0.28) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lyell Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyell Immunopharma. If investors know Lyell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyell Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lyell Immunopharma is measured differently than its book value, which is the value of Lyell that is recorded on the company's balance sheet. Investors also form their own opinion of Lyell Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Lyell Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyell Immunopharma's market value can be influenced by many factors that don't directly affect Lyell Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyell Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyell Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyell Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.